TABLE 1.
Characteristics of patients enrolled in the study* β (n = 418)
| Baseline parameters | Total | Recovered patients | Hospitalised patients | Deceased patients |
|---|---|---|---|---|
| No. of patients | 418 (100) | 351 (83.97) | 60 (14.35) | 7 (1.67) |
| Age, (y), mean (SD) | 56.47 (±7.24) | 39.52 (±8.24) | 62.36 (±13.86) | 67.53 (±11.87) |
| Gender, female | 257 (61.48) | 211 (60.11) | 42 (70.00) | 4 (57.14) |
| Marital status, married | 357 (85.40) | 315 (89.74) | 38 (63.33) | 4 (57.14) |
| Educational level, below college | 178 (42.58) | 150 (42.73) | 26 (43.33) | 2 (28.57) |
| Smoking status, smokers | 188 (44.97) | 130 (37.03) | 53 (88.33) | 5 (71.42) |
| Anaemia, yes | 84 (20.09) | 49 (13.96) | 32 (53.33) | 3 (42.85) |
| Lymphocyte count, low | 225 (53.52) | 160 (45.58) | 59 (98.33) | 6 (85.71) |
| Chest CT, GGO | 251 (60.04) | 189 (53.84) | 54 (90.00) | 6 (85.71) |
| Symptoms appearance after exposure, mean (SD) | 3.63 (±1.84) | 4.81 (±2.84) | 2.13 (±0.82) | 1.98 (±0.98) |
| Polymorbidity, yes | 164 (39.23) | 99 (28.20) | 59 (98.33) | 6 (85.71) |
| Comorbidities | ||||
| COPD | 38 (9.09) | 7 (1.99) | 28 (46.66) | 3 (42.85) |
| Diabetes | 123 (29.42) | 84 (23.93) | 37 (61.66) | 2 (28.57) |
| Atrial fibrillation | 7 (1.67) | 2 (0.56) | 3 (5.00) | 2 (28.57) |
| Hypertension | 156 (37.32) | 98 (27.92) | 53 (83.33) | 5 (71.42) |
| Coronary artery disease | 12 (2.87) | 7 (1.99) | 3 (5.00) | 2 (28.57) |
| Hyperlipidemia | 148 (35.40) | 96 (27.35) | 50 (83.33) | 2 (28.57) |
| Heart failure | 35 (8.37) | 11 (3.13) | 22 (36.66) | 2 (28.57) |
| Liver disease | 16 (3.82) | 6 (1.70) | 9 (15.00) | 1 (14.28) |
| Renal disease | 34 (8.13) | 8 (2.27) | 22 (36.66) | 2 (28.57) |
| Cancer | 2 (0.47) | 0 (0.00) | 2 (3.33) | 0 (0.00) |
Abbreviations: COPD, chronic obstructive pulmonary disease; CT, computerised tomography; GGO, ground glass opacity; SD, standard deviation; β, no significant difference in baseline characteristics (all P > .05).
*
Items listed as numbers bed as proportions [n (%)] unless stated otherwise.